May 23, 2020
Sanofi, Regeneron’s Dupixent trial meets both co-primary endpoints
Dupixent in patients 12 years and older with eosinophilic esophagitis (EoE) trial met both of its co-primary endpoints.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: asthma study
December 19, 2016
GSK/Ivannova study Relvar/Breo once-daily cobination
GlaxoSmithKline and Innoviva have started a phase III study to compare certain triple combination asthma therapy with a double combination…
November 5, 2015
Verona Pharma completes inhibitor study
Verona Pharma has completed patient enrolment for the Phase IIa dose-finding study of RPL554 in asthma and the Phase IIa combination study of RPL554 in chronic obstructive pulmonary disease (COPD), in which the drug is being administered in addition to standard of care bronchodilators.